Difference between revisions of "Sequence-Based Predictions Hemochromatosis"

From Bioinformatikpedia
(Disorder)
(ProtFun)
Line 319: Line 319:
 
| style="border-style: solid; border-width: 0 0 0 0" |0.633*
 
| style="border-style: solid; border-width: 0 0 0 0" |0.633*
 
| style="border-style: solid; border-width: 0 0 0 0" |10.377*
 
| style="border-style: solid; border-width: 0 0 0 0" |10.377*
  +
|-
  +
| style="border-style: solid; border-width: 0 0 0 0" |Cellular processes
  +
| style="border-style: solid; border-width: 0 0 0 0" |0.095
  +
| style="border-style: solid; border-width: 0 0 0 0" |1.297
 
|-
 
|-
 
| style="border-style: solid; border-width: 0 0 0 0" |Central intermediary metabolism
 
| style="border-style: solid; border-width: 0 0 0 0" |Central intermediary metabolism
 
| style="border-style: solid; border-width: 0 0 0 0" |0.231
 
| style="border-style: solid; border-width: 0 0 0 0" |0.231
 
| style="border-style: solid; border-width: 0 0 0 0" |3.663
 
| style="border-style: solid; border-width: 0 0 0 0" |3.663
  +
|-
  +
| style="border-style: solid; border-width: 0 0 0 0" |Fatty acid metabolism
  +
| style="border-style: solid; border-width: 0 0 0 0" |0.016
  +
| style="border-style: solid; border-width: 0 0 0 0" |1.265
 
|-
 
|-
 
| style="border-style: solid; border-width: 0 0 0 0" |Purines and pyrimidines
 
| style="border-style: solid; border-width: 0 0 0 0" |Purines and pyrimidines
 
| style="border-style: solid; border-width: 0 0 0 0" |0.583
 
| style="border-style: solid; border-width: 0 0 0 0" |0.583
 
| style="border-style: solid; border-width: 0 0 0 0" |2.400
 
| style="border-style: solid; border-width: 0 0 0 0" |2.400
  +
|-
  +
| style="border-style: solid; border-width: 0 0 0 0" |Translation
  +
| style="border-style: solid; border-width: 0 0 0 0" |0.079
  +
| style="border-style: solid; border-width: 0 0 0 0" |1.801
 
|-
 
|-
 
| style="border-style: solid; border-width: 0 0 0 0" |Transport and binding
 
| style="border-style: solid; border-width: 0 0 0 0" |Transport and binding
Line 351: Line 363:
 
| style="border-style: solid; border-width: 0 0 0 0" |0.135
 
| style="border-style: solid; border-width: 0 0 0 0" |0.135
 
| style="border-style: solid; border-width: 0 0 0 0" |0.425
 
| style="border-style: solid; border-width: 0 0 0 0" |0.425
  +
|-
  +
| style="border-style: solid; border-width: 0 0 0 0" |Lyase
  +
| style="border-style: solid; border-width: 0 0 0 0" |0.049
  +
| style="border-style: solid; border-width: 0 0 0 0" |1.054
 
|-
 
|-
 
! style="text-align:left; border-style: solid; border-width: 0 0 2px 0" |Gene Ontology category
 
! style="text-align:left; border-style: solid; border-width: 0 0 2px 0" |Gene Ontology category

Revision as of 12:30, 18 May 2012

Hemochromatosis>>Task 3: Sequence-based predictions

Qc terxepssrw evi jypp sj aiewipw. Mrjsvq xli Uyiir, ws xlex wli qmklx wlss xliq eaec. Livi ai ks 'vsyrh xli qypfivvc fywl. Ks qsroic KS!

Aqw vjkpm K co etcba, dwv vjga ycpv aqw vq vjkpm vjcv. K mpqy ugetgvu. Mggr vjg rcpvcnqqpu. Cnycau mggr vjg rcpvcnqqpu.

Don't google it... but a hint: Caesar would solve it ;)


Short Task Description

Detailed description: Sequence-Based Predictions

Protocol

Protocol

Secondary Structure


Disorder

<figtable id="iupred">

Q30201
P10775
Q08209
Q9X0E6
TODO: description

</figtable>


Transmembrane Helices

<figtable id="tmh_q30201">

Q30201 TMH 1
PolyPhobius 306-329
UniProt 307-330
OPM no entry
PDBTM no entry
TODO: description

</figtable>


<figtable id="tmh_p35462">

P35462 (3PBL) TMH 1 TMH 2 TMH 3 TMH 4 TMH 5 TMH 6 TMH 7
PolyPhobius 30-55 66-88 105-126 150-170 188-212 329-352 367-386
UniProt 33-55 66-88 105-126 150-170 188-212 330-351 367-388
OPM 34-52 67-91 101-126 150-170 187-209 330-351 363-386
PDBTM 35-52 68-84 109-123 152-166 191-206 334-347 368-382
TODO: description

</figtable>


<figtable id="tmh_p47863">

P47863 (2D57) TMH 1 TMH 2 TMH 3 TMH 4 TMH 5 TMH 6 TMH 7 TMH 8
PolyPhobius 34-58 70-91 115-136 156-177 188-208 231-252
UniProt 37-57 65-85 116-136 156-176 185-205 232-252
OPM 34-56 70-88 98-107 112-136 156-178 189-203 214-223 231-252
PDBTM 39-55 72-89 95-106* 116-133 158-177 188-205 209-222* 231-248
TODO: description

</figtable>


<figtable id="tmh_q9ydf8">

Q9YDF8 (1ORQ/1ORS) TMH 1 TMH 2 TMH 3 TMH 4 TMH 5 TMH 6 TMH 7 TMH 8
PolyPhobius 42-60 68-88 108-129 137-157 163-184 196-213 224-244
UniProt 39-63 68-92 97-105* 109-125 129-145 160-184 196-208* 222-253
OPM (1ORS) 38-59 68-91 99-110 113-120 130-161
OPM (1ORQ) 166-185 196-208 220-238
PDBTM (1ORS) 40-63 68-88 101-120 131-155
PDBTM (1ORQ) 34-65 70-93 164-184 222-249
TODO: description

</figtable>


Signal Peptides

<figtable id="signalp">

Q30201
P47863
P11279
P02768
TODO: description

</figtable>


GO Terms


GOPET

<figtable id="gopet">

GOid Aspect Confidence Go term
GO:0004872 F (Molecular Function Ontology) 91% receptor activity
GO:0030106 F (Molecular Function Ontology) 88% MHC class I receptor activity
TODO: description

</figtable>


ProtFun

<figtable id="protfun">

Functional category Probability Odds
Biosynthesis of cofactors 0.105 1.452
Cell envelope* 0.633* 10.377*
Cellular processes 0.095 1.297
Central intermediary metabolism 0.231 3.663
Fatty acid metabolism 0.016 1.265
Purines and pyrimidines 0.583 2.400
Translation 0.079 1.801
Transport and binding 0.732 1.785
Enzyme/nonenzyme
Enzyme 0.208 0.727
Nonenzyme* 0.792* 1.110*
Enzyme class
Hydrolase 0.135 0.425
Lyase 0.049 1.054
Gene Ontology category
Signal transducer 0.201 0.939
Receptor 0.353 2.076
Stress response 0.274 3.108
Immune response* 0.381* 4.486*
TODO: description

</figtable>